Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now          
Bio B2BACT Genomics 〉Fusion Gene Testing

Fusion Gene Testing

Fusion Gene Testing

Most powerful in targeted therapy, especially for TRK inhibitor.
NGS panel design of 31 genes and provide medical report in 12 calendar days.

Request for Collaboration
Overview
ACTFusionTM  : Fusion Gene Testing is used to examine the genetic mutations in cancer patients for their personalized treatment plan. It is a breakthrough product to support current clinical guideline. Using next generation sequencing (NGS) to test 31 fusion genes and 182 transcripts, ACTFusionTM provides opportunities to use new targeted therapy across multiple cancers.
 
Features
  • Most powerful in targeted therapy selection especially tissue-agnostic ones
  • NGS panel design of 31 genes and 182 transcripts for targeted therapy
  • AI-powered bioinformatics analysis of cancer genetic mutations 
  • High-quality test result in CAP-certified lab
  • Fast turnaround time with 12 calendar days  
Specifications
  • Next Generation Sequencing : 31 fusion genes & 182 transcripts
  • NGS Sequencing Mean Depth :>800 X
  • Sample Types : FFPE (5-20 unstained sections : 10µm/slide and 1H&E stained slide : 5µm)                                                              *Cell block from pleural effusion, ascites or pericardial hydrops (≥1X106cells)
Application
All solid tumor patients including common cancer types such as breast, lung, colorectal cancer.
Especially powerful to find effective drug options in the following situations:
  •  Looking for new targeted therapy options
  •  Patients planning to use targeted therapy
Collaboration Options
  • Clinical Services : Provide cancer genomic profiling to enable personalized treatment plan.
  • Biomarker Discovery : We provide comprehensive cancer genomic profiling to facilitate biomarker discovery. Customized assay is available.
  • Patient Stratification : From next generation sequencing, IHC and PCR assay, we utilize various platforms to screen patients prospectively.
  • Consultation : Our team of industry veterans and in-house clinical database offer insights to ensure smooth clinical trial operations.
  • CDx Development : We offer companion diagnostic development on NGS-based or CHIP-based multiplex qPCR platforms.
People who like this also like
  • CRC ProtectCRC Protect
  • Pemetrexed Lyo Inj.Pemetrexed Lyo Inj.
  • TBx-Tissue BiopsyTBx-Tissue Biopsy
  • XUC™ InsertXUC™ Insert
  • AmCAD USAmCAD US
  • Synovial Fluid SupplementSynovial Fluid Supplement
  • MPB1734: an anti-cancer Nano Micelle drugMPB1734: an anti-cancer Nano Micelle drug
  • Smart Care PillowSmart Care Pillow
  • Horus Digital Diagnostic Set _DSC 200PHorus Digital Diagnostic Set _DSC 200P
  • PAX1 DNA Detection KitPAX1 DNA Detection Kit